Hologic, Inc. revised revenue results for the First Quarter of Fiscal 2023 . The Company expects to report total revenues of approximately $1,074.2 million, a decrease of (27.0%) compared to the prior year period, or (25.1%) in constant currency. These preliminary results are higher than the Company's most recent revenue guidance range of $940 to $990 million, which was provided on October 31, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
74.25 USD | +0.05% | +1.61% | +3.92% |
06-27 | Stephens Initiates Coverage on Hologic With Overweight Rating, $87 Price Target | MT |
06-19 | Lumos Diagnostics Receives $400,000 in Milestone Payment from Hologic; Shares Up 3% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.92% | 17.33B | |
+4.18% | 211B | |
+8.00% | 185B | |
+31.86% | 158B | |
+33.21% | 113B | |
+2.28% | 64.32B | |
+21.14% | 55.66B | |
+0.11% | 48.41B | |
-6.76% | 37.82B | |
+0.78% | 35.57B |
- Stock Market
- Equities
- HOLX Stock
- News Hologic, Inc.
- Hologic, Inc. Revises Revenue Results for the First Quarter of Fiscal 2023